EU and China Agree to Launch Consultations on Inverter Market Access
nashnova research
After reaching a 16-point trade deal, the EU agreed to consult with China on inverter market access — Sungrow rose as much as 3.3% intraday — but whether import curbs actually ease depends on what comes next.
What did the EU restrict on inverters?
In May, the EU imposed import curbs on inverters used in EU-funded projects, targeting suppliers deemed "high-risk vendors."
An inverter — the device that converts DC power from solar panels into AC power for the grid — is a critical link in the solar supply chain.
This means → if a Chinese inverter leader is labeled "high-risk," it loses access to EU public-project contracts outright.
What does this consultation pledge actually deliver?
China's commerce ministry said the EU agreed to "hold consultations on market access" for products including inverters, and clarified its policy as country-neutral.
In plain terms = the EU did not withdraw the curbs — it agreed to talk. "Country-neutral" means the EU says the policy is not aimed specifically at China.
The pledge is a side arrangement within the broader 16-point deal, whose core term is Beijing's agreement to cut exports of millions of hybrid vehicles.
How did the market react?
Sungrow Power Supply (陽光電源) rose as much as 3.3% intraday in Shenzhen — the most direct beneficiary.
This reflects the market pricing in a positive signal: Sungrow derived over 70% of first-half revenue from overseas, making it the company most exposed to the EU curbs.
But consultation ≠ relaxation. The stock move prices in improved expectations, not a policy change.
What should investors watch next?
Whether talks advance in substance depends on concrete arrangements in follow-up negotiations — no timeline has been set.
In plain terms = this is "agreeing to talk," not "a deal reached." Investors need to track whether consultation translates into actual policy adjustment.
For the Chinese inverter sector, this is a directional thaw signal — far from an all-clear.
市场有风险，内容仅供研究参考，不构成投资建议。